Health ❯ Healthcare ❯ Clinical Trials ❯ Drug Efficacy

Patient Outcomes

FDA Clears Lilly’s Foundayo Pill, Escalating GLP-1 Weight-Loss Rivalry

The approval accelerates a shift toward oral GLP-1 treatments that promise wider, steadier access.

Metsera’s Obesity Drug Posts 14% Placebo-Adjusted Weight Loss, Bolstering Pfizer Buyout Case